Details of the Drug Reposition

General Information of This Drug (ID: DMD1VZL)

Drug Name
Pemafibrate   DMD1VZL
Synonyms K-877
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hyperlipidemia DIS61J3S 5C80.Z Approved [1]
------------------------------------------------------------------------------------
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lipid metabolism disorder DISEOA7S 5C52.Z Phase 3 [2]
Cardiovascular disease DIS2IQDX BA00-BE2Z Phase 3 [3]
------------------------------------------------------------------------------------

References

1 Pemafibrate: First Global Approval. Drugs. 2017 Oct;77(16):1805-1810.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032781)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)